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1. In~oduction 
The presence of blood group Lewis (Le) antigens 
of glycosp~ngo~pid nature in human plasma was 
made probable through the work of Marcus et al. [ 11. 
Recently, several I_e active glycosp~ngo~pids were 
isolated and partially characterized from 8 1 pooled 
human plasma obtained from 40 donors 1231. The 
sparse occurrence on cell surfaces or in body fluids of 
these substances is a major problem in chemical stud- 
ies of the individual expression of blood group glyco- 
lipids. We have developed specific and sensitive tech- 
niques based on mass pectrometry [4,5] and NMR 
spectroscopy [6-81 for the identification of blood 
group antigens. Mass spectromet~ may give conclu- 
sive information on separate saccharide sequences 
also in mixtures [5 1. NMR spectroscopy may estab- 
lish the anomerity along the saccharide chain and also 
discriminate between type 1 (GM1 -+ 3 GlcNAc) and 
type 2 (Galpl + 4 GlcNAc) saccharide chains [6-81. 
These methodologic~ developments were essential 
for the specific detection of an Leb hexaglycosyl- 
ceramide in plasma of a human donor. 
2. Materials and methods 
One transfusion unit (450 ml) of fresh human 
blood (0, Rh-, I&a-b+), secretor) in acid-eitrate- 
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dextrose solution was received from the blood bank 
at Sahlgren’s hospital in Giiteborg. Plasma was imme- 
diately removed, carefully avoiding the buffy coat 
after centrifugation and recentrifugation. The cell- 
free plasma was stored at -2O’C before lipid extrac- 
tion. The cells were washed 5 times with 1 vol. saline. 
Cell membranes were prepared by toluene flotation 
[9] and lipid extraction took place within 24 h after 
blood donation. 
Methanol (250 ml) was added to -250 ml plasma 
or toluene-flotated red blood cell membranes of
1 transfusion unit and the mixture was heated to 
+70bC under constant stirring for 30 min. The extract 
was filtered and the filtrate was transferred back to 
the extraction bottle. The procedure was repeated 
twice with 250 ml chloroform:methanol, 2: 1 (v/v) 
and one with 250 ml methanol. The combined 
extracts were evaporated to dryness with the addition 
of small volumes of toluene. The dry lipid extract was 
subjected to mild aikaline hydrolysis, dialysis, DEAE- 
cellulose and silicic acid chromato~aphy [lo]. Alkali- 
stable nonglycolipids were removed by silicic acid 
~~omatography of acetylated lipids [ f 11. 
An MS 902 mass pectrometer (AEL Ltd, 
Manchester) was used, equipped with a direct inlet 
system and a separate probe heater. The mass pec- 
trometer was connected on-line to a computer system 
(Datamass One, Kratos-Instem Ltd, England). A 
Bruker 270 MHz NMR ~str~ent was used in the 
pulsed Fourier transform mode. Spectra were taken 
up in 8 K memory with a band-width of 3000 HZ and 
an acqu~ition time of 1.37 s. Chemical shift values 
are given in ppm relative to tetramethylsilane and the 
residual solvent peak was used as an internal standard. 
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3. Results and discussion 
Fig.1 shows the thin-layer chromatographic pat- 
tern of the total non-acid glycosphingolipids of cells 
and plasma, respectively. One-fourth of the plasma 
fraction (2 mg) was permethylated [ 121 and sub- 
jected to mass spectrometry. By a successive record- 
ing of spectra during heating of the sample in the ion 
source the presence of major glycolipids with l-4 
sugars was established (cf. fig.1). These have been 
characterized chemically before [ 131. Late in the 
evaporation a spectrum was recorded (fig.2) which is 
very similar to the spectrum of an Leb-like hexagly- 
cosylceramide in [ 141. The only terminal sugar found 
H-7 ------- 
Fig.1. Thin-layer chromatogram of the total nonacid glyco- 
sphingolipid fractions obtained from red blood cell mem- 
branes, lane 1, and plasma, lane 2, of a blood group 0, 
Le(a-b+) human donor. The amounts spotted on the thin- 
layer plate correspond to the same amount of whole blood 
(1 ml). The figures to the right indicate the number of sugars 
found in the carbohydrate chain. The 3 bands for 6 sugars 
probably represent glycolipids with different ceramide spe- 
cies but with the same oligosaccharide. The major component 
in the membrane fraction, lane 1, probably globotetraosyl- 
ceramide (4 sugars). The band just below this is an Hactive 
pentaglycosylceramide (H-5). H-active glycosphingolipids 
with 7 (H-7) and 10 (H-10) sugars are also indicated. For 
anlytical thin-layer chromatography HPTLC-Fertigplatten 
with Kieselgel 60 were used (Merck). The solvent was chloro- 
form:methanol:water, 60:35:8 (by vol.), and detection rea- 
gent was anisaldehyde [lo]. 
50 
-3GalUl--4 
GallIt- 
, _y&'" 
2 
I\ F"c"I-4 '\ - 
40 
n (rem1 
Fig.3. Top: Partial NMR spectrum of a permethylated-reduced 
glycosphingolipid mixture from plasma. The spectrum was 
recorded in ‘H-chloroform solution (1.4 mg in 0.5 ml). 
5600 pulses were recorded at 40°C. Middle: The same as top 
spectrum but reproduced with higher amplification. Bottom: 
Spectrum of permethylated-reduced Leb active hexaglycosyl- 
ceramide, Fucol --+ 2 Gal@1 + 3 GlcNAc(4 + lorFuc)pl + 
3 Galpl --f 4 Glcpl + 1 ceramide [ 81. 1.2 mg in 0.5 ml 
*H-chloroform. 1750 pulses at 40°C. 
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was fucose as shown by m/e 189 and 157. The 
sequence proposed in the formula is given by peaks at 
m/e 812 and 780 (terminal tetrasaccharide) and 
1032,1016 and 1000 (pentasaccharide). The rear- 
rangement ion indicated at m/e 402 is probably com- 
posed of the hexosamine and fucose and is only 
formed from a type 1 chain. 
The remaining part of the permethylated sample 
was reduced with LiAl H4 and subjected to NMR 
analysis (tig.3). With a basis in reference spectra [6], 
anomeric signals originating from mono-, di-, tri- and 
tetraglycosylceramide are easily recognized (top spec- 
trum). After amplification (middle spectrum) also 
specific signals of the less abundant hexaglycosyl- 
ceramide are discernable. Two isomeric structures 
with the sequence proposed in fig.2 are known, one 
based on a type 1 (Leb) and the other on a type 2 
chain. NMR spectra of both have earlier been recorded 
and shown to have specific differences [ 81. Weak but 
definite signals are indicated (middle spectrum) cor- 
responding to the anomeric protons of the terminal 
tetrasaccharide of the reference Leb glycolipid with a 
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Fig.4. Mass spectrum of the permethylated-reduced plasma glycosphingolipid mixture. A simplified formula is shown for the 
interpretation. The spectrum was recorded at 275°C. For further details, see fig.2. 
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type 1 chain (bottom spectrum). The presence of the 
signal at 5.16 ppm and the absence of a Fucal -+ 3 
signal at 5.78 ppm (type 2 chain) are highly diagnos- 
tic [8]. 
The reduced sample was finally subjected to mass 
spectrometry, using the same procedure as for the 
non-reduced mixture. During the evaporation a num- 
ber of spectra were taken confirming the presence of 
mono-, di-, tri- and tetraglycosylceramides. At high 
temperature a spectrum was recorded (fig.4) which 
gave additional support for the presence of the hexa- 
glycosylceramide proposed. Fragments represented 
by the series of peaks from m/e 1503 to 1645 con- 
tained the complete saccharide and a fatty acid, one 
series (1503,1587,1601 and 1615) with non-hydroxy 
fatty acids (16:0,22:0,23:0 and 24:0, respectively) 
and one series (1533,1617,1631 and 1645) with 
hydroxy fatty acids (16:0,22:0,23:0 and 24:0, 
respectively). Sequence information was given by m/e 
157,189,798,814,970,1002and1206. 
Although all analyses were done on a mixture of 
glycosphingolipids, the structural identity of the 
hexaglycosylceramide with an Leb determinant is 
very probably. This was in agreement with the Leb 
activity of the total glycolipid fraction (unpublished). 
In addition, selected ion monitoring [5] of the 
reduced sample gave strong evidence for the presence 
of small amounts of a monofucosyl pentaglycosyl- 
ceramide. This is probably an Lea-like structure [3] 
and is seen as a faint band in fig.1. 
The 3 bands in the 6-sugar region of the chromat- 
ogram (fig.1) may be explained to originate in the 
same hexasaccharide bound to a heterogeneous cera- 
mide. Both hydroxy and non-hydroxy fatty acids 
were shown (fig.4) as well as dihydroxy- and tri- 
hydroxy-bases (shown by m/e 364 and 396 of fig.2, 
respectively). This ceramide composition differs from 
that of erythrocyte ABH fucolipids, which contain 
only non-hydroxy acids and dihydroxy base [ 121. It 
is known that the weak Le activity of erythrocytes is 
taken up from plasma [ 131 but Le glycolipids of 
erythrocytes have not yet been reported. 
The present preparation was done on 200 ml 
plasma equivalent to 1 transfusion unit but the actual 
analyses were performed on substance from -50 ml. 
A number of blood group antigens reported to be 
present in human plasma [ 151 may now be chemi- 
cally characterized from single donors. We have found 
that already at the stage of thin-layer chromatog- 
raphy in the analysis procedure (fig.1) there are inter- 
esting differences in the 5-8-sugar region for glyco- 
lipids of donors of separate blood groups (in prepara- 
tion). 
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